EP2136707A1 - Diagnostische und prognostische hilfsvorrichtung für physiopathologische gewebeveränderungen - Google Patents
Diagnostische und prognostische hilfsvorrichtung für physiopathologische gewebeveränderungenInfo
- Publication number
- EP2136707A1 EP2136707A1 EP08736401A EP08736401A EP2136707A1 EP 2136707 A1 EP2136707 A1 EP 2136707A1 EP 08736401 A EP08736401 A EP 08736401A EP 08736401 A EP08736401 A EP 08736401A EP 2136707 A1 EP2136707 A1 EP 2136707A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- speckle
- tissue
- angle
- observation
- figures
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000001427 coherent effect Effects 0.000 claims abstract description 13
- 238000000034 method Methods 0.000 claims description 41
- 238000003745 diagnosis Methods 0.000 claims description 25
- 230000003902 lesion Effects 0.000 claims description 24
- 238000012545 processing Methods 0.000 claims description 15
- 238000004393 prognosis Methods 0.000 claims description 14
- 230000008569 process Effects 0.000 claims description 12
- 238000012986 modification Methods 0.000 claims description 11
- 239000004744 fabric Substances 0.000 claims description 10
- 230000004048 modification Effects 0.000 claims description 10
- 230000010287 polarization Effects 0.000 claims description 9
- 230000033001 locomotion Effects 0.000 claims description 8
- 230000003287 optical effect Effects 0.000 claims description 8
- 230000004796 pathophysiological change Effects 0.000 claims description 7
- 238000005286 illumination Methods 0.000 claims description 5
- 238000007619 statistical method Methods 0.000 claims description 5
- 238000011156 evaluation Methods 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 3
- 238000013016 damping Methods 0.000 claims description 2
- 230000009759 skin aging Effects 0.000 claims description 2
- 238000012623 in vivo measurement Methods 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 description 59
- 238000005259 measurement Methods 0.000 description 38
- 210000003491 skin Anatomy 0.000 description 37
- 238000013459 approach Methods 0.000 description 25
- 235000015277 pork Nutrition 0.000 description 23
- 239000010410 layer Substances 0.000 description 21
- 230000005653 Brownian motion process Effects 0.000 description 20
- 238000005537 brownian motion Methods 0.000 description 20
- 230000006870 function Effects 0.000 description 18
- 241000282887 Suidae Species 0.000 description 17
- 241000282898 Sus scrofa Species 0.000 description 13
- 230000005855 radiation Effects 0.000 description 10
- 210000004207 dermis Anatomy 0.000 description 9
- 238000009792 diffusion process Methods 0.000 description 9
- 238000001727 in vivo Methods 0.000 description 9
- 230000001575 pathological effect Effects 0.000 description 9
- 230000006399 behavior Effects 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000005311 autocorrelation function Methods 0.000 description 7
- 230000007170 pathology Effects 0.000 description 7
- 230000003595 spectral effect Effects 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 230000017074 necrotic cell death Effects 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010039710 Scleroderma Diseases 0.000 description 4
- 238000000540 analysis of variance Methods 0.000 description 4
- 238000001574 biopsy Methods 0.000 description 4
- 238000004364 calculation method Methods 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 241000282412 Homo Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010053615 Thermal burn Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 238000013399 early diagnosis Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000036074 healthy skin Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 230000005865 ionizing radiation Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 description 3
- 238000000528 statistical test Methods 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000011327 histological measurement Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000002344 surface layer Substances 0.000 description 2
- 238000001931 thermography Methods 0.000 description 2
- 208000032484 Accidental exposure to product Diseases 0.000 description 1
- 206010070918 Bone deformity Diseases 0.000 description 1
- 102000003712 Complement factor B Human genes 0.000 description 1
- 108090000056 Complement factor B Proteins 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- 206010069808 Electrical burn Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 206010063562 Radiation skin injury Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010041303 Solar dermatitis Diseases 0.000 description 1
- 235000019892 Stellar Nutrition 0.000 description 1
- 201000009594 Systemic Scleroderma Diseases 0.000 description 1
- 206010042953 Systemic sclerosis Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 231100000818 accidental exposure Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000007321 biological mechanism Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000005460 biophysical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 238000007470 bone biopsy Methods 0.000 description 1
- 230000008822 capillary blood flow Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000035992 intercellular communication Effects 0.000 description 1
- 238000005305 interferometry Methods 0.000 description 1
- 238000012977 invasive surgical procedure Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 244000309715 mini pig Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000513 principal component analysis Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000005295 random walk Methods 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007390 skin biopsy Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005309 stochastic process Methods 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000036575 thermal burns Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/445—Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/44—Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
- A61B5/441—Skin evaluation, e.g. for skin disorder diagnosis
- A61B5/444—Evaluating skin marks, e.g. mole, nevi, tumour, scar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0233—Special features of optical sensors or probes classified in A61B5/00
- A61B2562/0242—Special features of optical sensors or probes classified in A61B5/00 for varying or adjusting the optical path length in the tissue
Definitions
- the present invention relates to a device for measuring the properties of biological tissues in vivo for the diagnosis and prognosis of physiopathological changes in these tissues.
- Cutaneous radiological burn is a syndrome whose clinical effects are known but are difficult to predict, either in the short or the long term. Indeed, unlike the thermal burn, the visible consequences of this burn (erythema, edema, necrosis, ...) do not appear immediately after exposure to the source of irradiation.
- a variable latency time depends in particular on the irradiation dose, the volume of irradiated tissue, the irradiation source, the duration of exposure and the response specific to each individual. This biological latency time is also called clinically silent phase.
- Radiological burn is a clinical situation that can be encountered in the context of accidental exposure to ionizing radiation but also in the context of controlled exposure to radiotherapy. Regarding radiation accidents, unfortunately still too frequent today, nearly 600 radiological accidents have been recorded in the world since 1945.
- the biopsy allows to highlight an irradiated tissue and to evaluate the received dose: histological measurements on a skin biopsy make it possible to highlight the irradiation of the tissue, and the bone biopsy makes it possible to quantify precisely the dose received by Electron Paramagnetic Resonance (EPR).
- EPR Electron Paramagnetic Resonance
- the biopsy is an invasive surgical procedure that surgeons fear because it is likely to aggravate the condition of the tissue already weakened by irradiation.
- Radiotherapy nearly 30% of patients develop cutaneous toxicity and 5% of patients unfortunately develop severe complications. Radiation therapy is based on optimizing the prescribed dose to destroy the tumor while preserving surrounding healthy tissue included in the radiation field. The risk of secondary complications related to exposure of healthy tissues to ionizing radiation is therefore unavoidable.
- the severity of these lesions depends on several factors such as the radiosensitivity of the tissue, the dose, the frequency of exposure or the pathological history of the patient. Acute toxicity of radiotherapy to cutaneous tissue may result in discontinuation of treatment.
- infrared thermography and the Doppler laser make it possible to discriminate the irradiated zone of the healthy zone during the first 48 hours after irradiation in a locally irradiated dwarf pig (in English, mini pig) (40 Gy). Beyond the forty-eighth hour after irradiation, these techniques did not make it possible to differentiate the healthy skin from the irradiated skin.
- Table 1 summarizes the different biophysical and biological techniques that are proposed according to the clinical course of lesions (see document [3]). However, none of these techniques never made it possible to demonstrate an irradiated tissue compared to a healthy tissue in the absence of visible clinical signs. These techniques are not used clinically for the diagnosis and prognosis of cutaneous irradiation.
- the present invention aims to remedy this disadvantage.
- the technique, object of the invention, and its valuation on a pre-clinical model constitute a progress for the early diagnosis and prognosis and the health of the patient.
- the device, object of the invention allowing the acquisition and the treatment of speckle figures in particular by a fractal approach, constitutes an advantageous tool for the aid, in vivo, to the diagnosis of the radiological burn and to the prognosis of its evolution.
- the diagnostic and prognostic value of this device has been validated.
- the present invention relates to a device for measuring in vivo the properties of biological tissues, in particular for the diagnosis and prognosis of physiopathological changes, including tissue lesions and more particularly by irradiation, for the evaluation of skin aging, for the evaluation of the effectiveness of cosmetological or dermatological products, this device being characterized in that it comprises: a coherent light source for emitting a coherent light according to a first direction, for illuminating a biological tissue in first and second zones thereof, the first zone being healthy and the second zone being capable of comprising modifications, the fabric thus illuminated generating a speckle phenomenon,
- observation and acquisition means for observing the speckle field in a second direction and acquiring the speckle, means (mechanical or otherwise) for varying the angle between the first and second directions, to observe the field of view; speckle from different angles, in order to acquire information about the tissue at different depths of this tissue,
- means in order to allow comparison of the first and second zones, means (mechanical or otherwise) for holding and damping to maintain a constant distance between the point of illumination of the surface of the fabric and the observation means and acquisition and to dampen possible movements of the tissue, due to external factors, for example breathing, electronic means for processing the speckle figures obtained by means of the observation and acquisition means, in order to compare the first and second zones, and electronic means for analyzing the processing of the figures, by statistical methods, making it possible to validate the comparison made between the first and second zones.
- the means of variation of the angle allow the acquisition of the speckle at several angles of observation and thus the exploration of the tissue at several depths and, consequently, the taking into account of physiopathological changes of different layers of the tissue.
- the statistical methods mentioned above are, for example, statistical tests or factorial analyzes.
- the means for varying the angle between the first and second directions are able to vary this angle in the range of substantially 0 ° to 180 ° and to allow to observe the speckle outside the specular reflection, at several angles with respect to the direction of this specular reflection. This embodiment thus allows the preferred exploration of the different tissue layers at different depths.
- the means for varying the angle between the first and second directions are able to modify the orientation of the first direction independently of that of the second direction and vice versa.
- the observation and acquisition means comprise photodetection means which pick up the speckle and supply electrical signals representative of the corresponding speckle figures, and the electronic processing means are able to process the electrical signals in the form of uncompressed images, and to make it possible to compare the first and second zones.
- the photodetection means are capable of capturing the speckle with exposure times of at most 100 ⁇ s.
- the photodetection means preferably comprise a camera.
- the camera is preferably a camera without a lens but can also be a camera with a lens.
- the camera is for example a CCD camera.
- the observation and acquisition means are designed to acquire at least 200 speckle figures per illuminated area.
- the device which is the subject of the invention, may furthermore comprise optical means which are able to control the polarization of the coherent light emitted by the source and the polarization of the light arriving on the observation and acquisition means, to complete the selection of the speckle from the more or less deep layers of the fabric.
- optical means comprise polarizers (linear, circular or elliptical) and / or half or quarter wave plates.
- the coherent light source is monochromatic.
- This source is preferably a laser.
- the distance between the point of illumination of the fabric surface and the camera is preferably about 20 cm.
- the processing of the speckle figures can be performed by a conventional frequency method and / or by a fractal method.
- this treatment comprises the extraction of stochastic parameters which are characteristic of the speckle figures.
- the stochastic parameters comprise:
- FIG. 1 is a diagrammatic view of a particular embodiment of the object device of FIG.
- FIGS. 2a and 2b show, in the case of the conventional frequency approach, the average size of the speckle grains for each measurement point and for each zone, namely a healthy zone (dotted lines) and an irradiated zone (lines continuous), as regards the width of the grains dx
- FIGS. 3a, 3b and 3c show, in the case of the fractal approach, fractal parameters, calculated according to the horizontal dimension of the image, for each measurement point and for each zone, namely a healthy zone (lines dotted) and an irradiated zone (continuous lines), with respect to the saturation of the variance G (FIG. 3a), the self-similarity S (FIG. 3b) and the Hurst coefficient H (FIG. 3c), for the pig mentioned more high, with the same angle of incidence of the light beam,
- FIG. 4 shows photographs of the irradiated zone of the skin of the pig mentioned above on the measurement dates (40 Gy),
- FIG. 5 is a representation of the scores on the different experimental dates of the discriminant parameters for various angles, all pigs combined
- FIG. 6 shows the increase in the thickness of the epidermis and that of the dermis, for one zone. irradiated with respect to a healthy zone (in%) for four pigs,
- FIG. 7 shows the evolution of the ratio 40 Gy / 0 Gy for an observation angle of 20 °, for three stochastic coefficients, namely the saturation of the variance G, the self-similarity S and the coefficient of Hurst H, according to the dates of measurement, all measurement points combined, for pork numbered P129
- figure 8 shows the evolution of the Hurst H coefficient as a function of time, for each zone, namely a healthy zone (dashed lines) and an irradiated zone (lines continuous), all measurement points combined, for the observation angle of 60 ° and the pig numbered P161,
- FIG. 9 shows the spectral power density of a speckle figure (log-log scale)
- FIG. 10 shows the normalized autocovariance function c ⁇ (x, 0), dx representing the half-height width of the function, and
- FIG. 11 is a log log (arbitrary unit) representation of the scattering function of a speckle figure, obtained in the case of healthy skin.
- the speckle is an interferential phenomenon, due to the interaction of a coherent light with a diffusing medium.
- a diffusing medium has local fluctuations in density and therefore in refractive index.
- These local zones, randomly distributed in the medium, constitute partial wave diffusers.
- the random phase shift of these partial waves causes random interferences that induce a statistical intensity distribution.
- speckle The intensity figure thus produced, with its grainy appearance, is called speckle.
- the fractal approach of the speckle is applied by the motion fractional brownian, proposed in document [12], to the discrimination, in vivo, of cutaneous pathologies.
- PSD Power Spectral Density
- the PSD of the experimental figures decreases according to a power law only in the high frequency domain, which confirms a self-similar (or scale invariance) behavior in this spectral domain.
- the size of the self-similar element S characterizing the separation of self-similar and conventional behaviors in the image, and the saturation of the variance G which gives the asymptotic direction to the large neighborhood values in the image.
- the speckle is recorded by a camera without objective and without any other imaging system, and in the second case, by a camera with a lens for example.
- Any modification of the scattering medium causes optical and statistical modifications of the medium, which causes the variation of the three stochastic parameters mentioned above.
- the idea is then to use these parameters which characterize the speckle image in order to differentiate the diffusing media.
- the diagnostic aid being an objective of the present invention, the application of this method is targeted on the living media, in particular on the skin syndrome of acute irradiation whose short and long-term evolution is still unknown. .
- This approach to the speckle phenomenon based on the fractal theory, is more powerful than the conventional frequency approach (these two approaches are described at the end of this description) since it incorporates the multi-scale aspect of the speckle.
- the device according to the invention which is schematically represented in FIG. 1, is used to record the speckle fields originating from biological tissues.
- This device is very simple and inexpensive. It comprises a non-polarized monochromatic laser 13 and a charge-coupled device camera 14, more simply called a "CCD camera".
- a diffusing medium 16 namely a healthy or pathological cutaneous zone, illuminated at a point P by the beam 29 issuing from the laser 13, gives rise to a speckle phenomenon.
- the light backscattered by the medium (cutaneous tissue) 16 is captured by the camera 14 which thus allows the acquisition of a speckle.
- N the direction of the normal at the surface of the biological tissue 16 at the point P
- X the direction of emission of the light by the laser 13
- Y the direction of observation of the field of the speckle by the camera 14.
- ⁇ the angle between the X and Y directions
- ⁇ the angle of incidence of the laser beam relative to the normal direction at the surface of the biological tissue
- ⁇ the angle of observation relative to the normal direction at the biological tissue surface
- the device of FIG. 1, according to the invention, allows the variation of the angle ⁇ (respectively ⁇ ) of the direction X (respectively Y) independently of the variation of the angle ⁇
- the device of FIG. 1 also comprises mechanical means comprising a mechanical support 18 and a mechanical guide 20.
- the mechanical support 18 supports the laser 13 and the camera 14 and allows a variation of the angle ⁇ and / or the angle ⁇ , to observe the speckle field from different angles. This variation of the angles ⁇ and / or ⁇ makes it possible to explore the tissue at different depths.
- the lower part of the guide 20 is rigidly secured to a torus 28 which defines the measurement zone.
- this torus is in contact with the surface of the fabric 16.
- the inner diameter of the torus is 40 mm in the example; it is then wide enough not to add parasitic reflections.
- Guide 20 and the torus 28 can maintain a constant distance L between the point of impact P of the laser beam 29 and the camera 14, between two consecutive acquisitions of speckle figure, and also allow to dampen possible movements of the fabric 16, for example due to breathing.
- the guide 20 and torus 28 then provide optimal acquisition of speckle figures for the essential comparison between the two areas (healthy and pathological).
- the mechanical support 18 is attached to the guide
- the support 18 in the form of a circular arc is chosen as a function of the maximum angle ⁇ that it is desired to obtain with the device: if it is desired to obtain an angle ⁇ substantially equal to 180 ° a support 18 forming substantially a semicircle is used.
- the device of Figure 1 also comprises electronic means 22 for processing, in accordance with the invention, the signals provided by the camera. These electronic means 22 are provided with display means 26. It is specified that, in accordance with the invention, the tissue 16 is illuminated by means of the laser 13 in a sound zone then in an area likely to contain modifications.
- the device of Figure 1 further comprises electronic means 24 for analyzing the signals processed according to the invention by the means 22, to validate the comparison of the two skin areas (healthy and pathological). The results obtained by these means 24 can also be displayed by the display means 26.
- the laser 13 is a non-polarized He-Ne laser (632.8 nm) of power 15 mW, which emits a beam whose width is of the order of 1 mm at I 0 / e 2 , where I 0 is the maximum intensity of the laser (radius of the beam for which the intensity has decreased by a factor 1 / e 2 with respect to its maximum I 0 ).
- the CCD camera 14 is for example of the Kappa CF 8/1 DX type, with 376 (H) ⁇ 582 (V) effective pixels; it is used without purpose; and each pixel measures 8.6 (H) x 8.3 (V) ⁇ m.
- the exposure time of the camera allows an exposure time of at least 100 ⁇ s.
- the camera is intended to acquire at least 200 speckle figures per illuminated area at a frequency of 25 Hz.
- the laser 13 and the camera 14 are not necessarily placed on either side of the guide 20: if necessary, for these measurements, they may be on the same side of this guide.
- a movable arm (not shown) holds the mechanical support assembly 18-guide 20, which supports the laser 13 and the camera 14, and allows their displacement to study different areas of the tissue 16.
- the displacement is carried out in translation and / or in rotation in the three directions of space in order to adapt to the measurements of the different zones to study the tissue 16.
- the invention can be implemented with other observation and acquisition means than a CCD camera and that the latter and the other cameras that can be used may or may not be provided with a lens for the camera. implementation of the invention. Similarly, the invention can also be implemented with a polarized laser.
- the selection of speckle from deep or surface layers of the tissue may be supplemented by an optical system 27, consisting of polarizers (linear, circular, or elliptical) and / or half or quarter wave plates.
- This optical system when used, is placed at the exit of the laser and / or the entrance of the camera.
- This optical system makes it possible to control the polarization of the coherent light illuminating the tissue and the polarization of the light arriving on the camera in order to detect several polarization states according to the polarization configuration chosen at the exit of the laser.
- Polarizers with or without half blades or quarter wave are configured to preferentially select the speckle from the surface layers of the fabric or the speckle from layers more or less deep.
- the cutaneous effects of the skin syndrome of acute irradiation in several pigs were taken as examples of application of the device according to the invention: the pigs were irradiated locally (40 Gy) by gamma radiation on the right flank, on an area of dimension 5 cm x 10 cm.
- the speckle figures obtained are processed by successively illuminating the two zones (healthy and pathological), at several angles ⁇ ranging from 20 ° to 60 ° and by detecting the backscattered light at a fixed angle ⁇ , chosen equal to 0 °; this treatment is carried out by a conventional frequency method and a fractal method: the CCD camera 14 provides electrical signals representative of the speckle figures and the electronic processing means 22 process these signals by the two methods mentioned above, in the form of uncompressed images, and compare the two areas. This comparison is validated by the electronic means of statistical analysis 24 (statistical tests such as Student's tests and analysis of variance tests, or factorial analyzes such as, for example, Principal Component Analysis).
- the recording of speckle figures requires some precautions.
- speckle is produced by a living medium containing consequently movable diffusers whose movement can be regarded as random.
- These temporal fluctuations are usually described by the temporal autocorrelation function of intensity (see [19]).
- the acquisition time of a speckle image must be as short as possible in order to avoid recording this "scrambled" speckle.
- the camera allows a variable exposure time, we choose the lowest acquisition time, equal to 100 microseconds, despite the possible loss of a proper signal-to-noise ratio.
- the size of speckle grains increases linearly with distance (see [20]).
- the recorded speckle grains should be quite large compared to the CCD camera pixel size, which implies that this camera should not be too close to the scattering medium.
- each image must contain enough grains to perform a meaningful statistical study of each image, which implies for the camera not to be too far from the middle. It is difficult to find the distance L between the CCD sensor and the illumination point of the diffusing medium, ideally respecting these conditions. A compromise must therefore be found.
- the chosen distance L was 20 cm for the pork skin. This choice is purely indicative and not limiting.
- the distance L must be identical for the first and second zones, that is to say the healthy zone and the area likely to be damaged.
- observation and acquisition of the field speckle are carried out outside the specular reflection to more or less 10 °.
- a series of images is recorded by the CCD camera with a frequency of 25 Hz.
- a complete video image is composed of two fields acquired one after the other: an even field (composed of the even lines 2, 4, 6, ...) and an odd field (consisting of odd lines 1, 3, 5, ).
- 50 fields (even and odd) will be delivered per second to obtain a complete image at a frequency of 25 Hz.
- the images are acquired on a single field (even or odd) since the image changes between the acquisition of an even field and an odd field.
- the dimensions of an image are 288x384 instead of 576x384 for a complete uncompressed image.
- the analog signal delivered by the camera is then digitized on 8 bits by an image acquisition card that measures the intensity on a scale of gray levels up to 256.
- the number of images acquired is 200 per measurement point (corresponding to the point of impact of the laser beam P) at a frequency of 25 images per second and with an acquisition time of 100 ⁇ s.
- Several measurement points are made for each analyzed area of skin (healthy zone and pathological zone).
- speckle images are then processed to determine the "speckle size" (average grain size of a speckle image), by a conventional frequency method, recalled at the end of the present description.
- the images are also processed line by line or column by column, by a fractal method, to determine the three stochastic coefficients as indicated at the end of the description.
- a calculated stochastic coefficient H, saturation of the variance G or S self-similarity
- H horizontal dimension
- G saturation of the variance
- the surface and the volume of diffusion are observed differently according to the position of the camera in the plane of the observation: the more the angle ⁇ between the direction of the observation and that of the normal to the fabric surface is large, the larger the scattering surface and volume seen by the camera.
- the larger the angle ⁇ is in front of ⁇ or conversely the larger the angle ⁇ is in front of ⁇ the less the energy flux captured by the camera takes into account the specular reflection.
- the probability of taking into account multicast photons, those coming from deeper layers of the skin increases with the difference in absolute value between the two angles ⁇ and ⁇ . It is recalled that we note this difference of angles, in absolute value, ⁇ and that it corresponds to the angle of observation with respect to the direction of the specular reflection. As a consequence, the more one deviates from the specular reflection, the more the probability that the measurements contain information coming from the volume is large; the information coming from the deep layers then predominates on those coming from the surface.
- the radiological burn it has been chosen to perform the measurements with a value of the angle of incidence of the laser beam ⁇ in the range from 20 ° to 60 ° and a value of the angle ⁇ fixed, chosen equal to 0 °.
- the angle of observation of the speckle with respect to the direction of the specular reflection ⁇ was then equal to that of the angle ⁇ .
- a pre-clinical study model has been developed specifically for the application of the invention to cutaneous irradiation in pigs. It is a calibrated model of localized irradiation in pigs, reproducibly simulating radiological burns in humans.
- Pork skin is the best known biological model of human skin.
- the irradiations are carried out by gamma radiation ( 60 Co, 1 Gy / minute).
- the pig is lying on its belly and arranged so that the axis of the irradiation beam is perpendicular to the axis of the spine.
- a block of wax about 1 cm thick is placed on the irradiated skin area to achieve electronic equilibrium conditions in the skin and thus obtain a better homogeneity of the dose in depth.
- Thermolumiscent dosimeters, made of alumina powder (AI2O3), are incorporated in the wax thickness to control the dose delivered to the skin.
- This experimental irradiation protocol was validated by a series of measurements on a simplified phantom, representative of the main characteristics of the pig (thickness and trunk height, skin density).
- Irradiations were carried out following this experimental protocol, at different doses, namely 5, 10, 15, 20, 40 and 60 Gy and allowed, under these experimental conditions, to select the dose of 40 Gy, dose at which signs of necrosis were observed.
- this latency phase is from D3 to D104, that is to say from 3 days to 104 days after the day of the irradiation which is noted OJ.
- gamma radiation irradiations 60 Co were performed locally on the skin of the pig, on a surface of 5 cm x 10 cm with a dose of 40 Gy. A series of measurements were made every 8 days approximately after irradiation. Eight measurement points were performed on each zone (healthy zone, corresponding to 0 Gy, and irradiated zone to 40 Gy) with 200 images for each point. To be sure to measure every experience in the same place on this skin, it has been tattooed on each area
- the discrimination between the healthy zone and the irradiated zone is then more than 99.8% significant for the Hurst coefficient and for the saturation of the variance.
- Self - similarity is "almost" discriminating if one takes a threshold of 0.01 for the index p A. However, it is the only series of measurements where its index is so low since for all the other measurements (corresponding to the other angles of incidence of the laser beam and the other dates) the index p A was too great for the discrimination ( p A > 0.023).
- Figure 4 shows photographs of pig skin (irradiated area) at all measurement dates.
- the Hurst coefficient H and the saturation of the variance G discriminate the irradiated area at J64 and J75 for the three viewing angles. From J84, only the Hurst coefficient discriminates at least for two of the three angles. This coefficient is more effective for discrimination.
- FIG. 5 is a graphical representation of the scores of the discriminant parameters for each angle, all pigs combined (pigs P129, P161, P163 and P164).
- the effectiveness of the diagnosis, in the case of the radiological burn, is then based on the observation of the deepest skin layers.
- the intermediate layers, visible essentially at 40 °, would not be subject to significant modifications in the case of radiological burn, which would explain the poor efficiency of this angle for discrimination.
- Figure 6 shows the increase in epidermal thickness and dermis thickness of the irradiated area relative to the healthy zone (in%) for the four pigs.
- Histology on the biopsy of healthy and irradiated zones makes it possible to quantify the level of cutaneous tissue involvement and to correlate the evolution of physical parameters with the corresponding biological modifications.
- the histological measurements taken at J112 for pork P129, J106 for pork P161, J92 for pork P163 and J168 for pork P164 show an increase in the thickness of the epidermis and dermis of:
- Table 6 shows the correlation coefficients (r) calculated between the parameters of the speckle, calculated according to the horizontal dimension of the image (G, S, dx and H), and the thicknesses of the epidermis and the dermis. Correlation calculations were performed considering all the measurement points and all four pigs studied. The significance of the test performed on the correlation coefficient is also indicated, with a threshold of the confidence index p chosen here of 0.005. The symbol ⁇ means "little different from”.
- the Hurst coefficient is lower for the irradiated zone, unlike the saturation of the variance, which is greater. Moreover, we can see an overall decrease in this ratio for the Hurst coefficient as a function of time, which indicates that it is the most effective stochastic coefficient for discrimination, as mentioned above.
- this stochastic approach is used to make it a diagnostic aid tool for radiation-induced skin injury.
- the speckle field acquisition device which is simple and inexpensive (FIG. 1), the protocol of the measurements, the treatment of these speckle figures by a fractal approach and by a conventional frequency approach described at the end of the present Description and analysis of the treatment of these figures by statistical methods making it possible to validate the comparison made between the healthy and pathological zones according to the invention, are advantageous tools for the aid, in vivo, to the diagnosis of this pathology and to the prognosis of its evolution.
- the device represented in FIG. 1 made it possible to discriminate the healthy zone of the irradiated zone during the clinically silent phase by at least one of the three observation angles used: 29 days before the appearance of the first lesion for pork P129, 20 days for pork P161, 57 days for pork P163 and 56 days for pork P164. Being able to discriminate the irradiated area when no lesion is visible is a very important and innovative point.
- the non-invasive observation of biological tissue at different depths evidenced by previous correlation studies, reveals the location of pathophysiological changes corresponding to observed speckle changes.
- the non-invasive exploration of biological tissue at different depths and allowing diagnosis and prognosis even though no clinical signs are visible is a very important and innovative point.
- the invention has been implemented by performing the processing of the speckle figures both by a conventional frequency method and by a fractal method. However, it is not beyond the scope of the invention to perform this treatment simply by a conventional frequency method or a fractal method or even by any other appropriate method.
- the core 28, placed at the base of the guide 20 can be replaced by any other means of delimitation of the studied surface, as long as this means allows the laser beam 29 to reach this surface and also allows the backscattered light to be detected.
- the mechanical means constituted by the support 18 and the guide 20 may be replaced by other non-mechanical means having the same functions, for example mechano-optical, acousto-optical or electro-optical means.
- the invention allows not only the pre-lesion discrimination, but also the obtaining of a prognostic system of the radiation-induced lesion and the realization of a mapping of the dose of the analyzed tissue.
- the invention can be used in the context of a broader biomedical application field than that of the diagnosis and prognosis of the cutaneous syndrome of acute irradiation.
- biomedical applications use as a tool to aid in the diagnosis of cutaneous lesions in general (cancer, local scleroderma, vitiligo, mycoses ).
- use as a tool to help in the diagnosis of radio lesions -induced following radiotherapy used as a tool to aid the diagnosis of lesions caused by accidental irradiation
- use as a tool to aid in the diagnosis of lesions caused by burns other than those caused by irradiation thermal, chemical, electrical burns, solar erythema
- use for the prognosis of cutaneous lesions in general radiological burns, thermal, chemical, electrical ..., local scleroderma, skin cancer ).
- tissue lesions cutaneous lesions, lesions of the mucous membranes, systemic scleroderma, cancer .
- the invention has two fields of application in the cosmetological field: - use for the evaluation of cutaneous aging, and use for evaluating the cosmetological or pharmacological efficacy of formulations or preparations for dermatological purposes.
- the advantage of the invention is, on the one hand, that it makes it possible to detect an effect before the latter is visible and, on the other hand, that it represents a diagnostic assistance tool that can be used in vivo and especially non-invasive.
- the low cost of the device object of the invention facilitates its miniaturization in order to make it an easily transportable tool for transfer to the clinic and for distribution in hospitals.
- the intensity has a decreasing exponential type distribution.
- the intensity observed is that which is detected by the camera and therefore corresponds to the spatio-temporal integration of this absolute intensity.
- the probability density function of the detected intensity I d can be written as the product of convolution of the absolute intensity and of a detection function H:
- the power spectral density (PSD) of a signal is defined as the square of the Fourier transform module of this signal.
- PSD power spectral density
- Figure 9 shows a power spectral density PSD, which is typical of experimental speckle figures, as a function of the spatial frequency f_, in log-log scale. We can see that the speckle figures have a decay called 1 // for high frequencies. This behavior is characteristic of a self-similar process in this frequency domain.
- R 1 (Ax, Ay) (1 (X 1 , J 1 ) I (X 2 , y 2 )) (6)
- R 1 (Ax 7 Ay) R 1 (X 1 ).
- the autocovariance function is defined as the autocorrelation function centered on the mean. When it is normalized, it is written:
- the autocorrelation function of the intensity is given by the inverse Fourier transform (denoted FT '1 ) of the PSD of the intensity: This expression is used for calculating the autocorrelation function.
- C j (x, 0) and C 1 (O, y) respectively correspond to the horizontal and vertical profiles of
- Figure 10 shows the horizontal profile c ⁇ (x, 0) versus x (in ⁇ m). This constitutes the classical frequency approach of the speckle phenomenon and allows then to spatially characterize a speckle figure by this which is called “the size of speckle", through the characteristics of its grains.
- Brownian motion is a mathematical description of the random motion of a suspended particle in a fluid that is not subjected to any other interaction than that of the fluid molecules.
- the path of the suspended particle is randomized by random fluctuations in the velocities of the fluid molecules.
- the amplitude of the speckle corresponds to a white Gaussian noise.
- Brownian motion is the integration white Gaussian noise.
- the detected intensity of the speckle then corresponds to a Brownian motion. Consequently, their first-order statistics are of the same nature: they are Gaussian for the amplitude distribution and the intensity distribution.
- Equation (11) corresponds to the expression of the process of increasing the fractional Brownian motion.
- Equation (11) is known as the diffusion equation.
- the fractal approach of the speckle by the fractional Brownian motion model is applied to the study of in vivo speckle from biological media. Fractional Brownian motion applied to the speckle phenomenon: diffusion function of a speckle figure.
- C g is the autocorrelation function of the intensity for the horizontal dimension of the image.
- the PSD of the speckle contains a decay in 1 // only for the high frequencies. This behavior for the high frequencies characterizes a local regularity on the trajectory of the increases.
- the autocorrelation function of a process that contains a local regularity is:
- H the Hurst coefficient
- D f d + 1-H
- H characterizes the fractal dimension of the image and is then a characteristic of grains. It is also a parameter of local regularity, as we saw above.
- G the saturation of the variance, equal to 2 ⁇ , 2 , characterizes the image globally.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0754570A FR2915077B1 (fr) | 2007-04-19 | 2007-04-19 | Dispositif d'aide au diagnostic et pronostic de modifications physiopathologiques des tissus. |
PCT/EP2008/054764 WO2008132079A1 (fr) | 2007-04-19 | 2008-04-18 | Dispositif d'aide au diagnostic et pronostic de modifications physiopathologiques des tissus |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2136707A1 true EP2136707A1 (de) | 2009-12-30 |
Family
ID=38668707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP08736401A Withdrawn EP2136707A1 (de) | 2007-04-19 | 2008-04-18 | Diagnostische und prognostische hilfsvorrichtung für physiopathologische gewebeveränderungen |
Country Status (6)
Country | Link |
---|---|
US (1) | US20100121200A1 (de) |
EP (1) | EP2136707A1 (de) |
JP (1) | JP5612463B2 (de) |
CA (1) | CA2683878C (de) |
FR (1) | FR2915077B1 (de) |
WO (1) | WO2008132079A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130237853A1 (en) * | 2012-03-12 | 2013-09-12 | Ivwatch, Llc | Geometry of a Transcutaneous Sensor |
JP6123061B2 (ja) * | 2012-08-10 | 2017-05-10 | アルスロデザイン株式会社 | ガイド器具設置誤差検出装置 |
EP2781191A1 (de) | 2013-03-19 | 2014-09-24 | Schnidar, Harald | Verfahren zur Beurteilung von Erythemen |
DE102015207119A1 (de) * | 2015-04-20 | 2016-10-20 | Kuka Roboter Gmbh | Interventionelle Positionierungskinematik |
JP2017116982A (ja) * | 2015-12-21 | 2017-06-29 | ソニー株式会社 | 画像解析装置、画像解析方法及び画像解析システム |
US10724846B2 (en) | 2016-05-23 | 2020-07-28 | ContinUse Biometrics Ltd. | System and method for use in depth characterization of objects |
PL425395A1 (pl) | 2018-04-30 | 2019-11-04 | Milton Essex Spolka Akcyjna | Aparat do multimodalnej analizy odczynu alergicznego w przebiegu testów skórnych oraz hybrydowa metoda multispektralnego obrazowania odczynów alergicznych w przebiegu testów skórnych i jej zastosowanie do automatycznej oceny wyniku tych testów |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2747489B2 (ja) * | 1988-06-24 | 1998-05-06 | 富士通株式会社 | 指紋センサ |
US5991697A (en) * | 1996-12-31 | 1999-11-23 | The Regents Of The University Of California | Method and apparatus for optical Doppler tomographic imaging of fluid flow velocity in highly scattering media |
US5897494A (en) * | 1997-01-31 | 1999-04-27 | The Board Of Trustees Of The University Of Arkansas | Vibrometer |
US5876342A (en) * | 1997-06-30 | 1999-03-02 | Siemens Medical Systems, Inc. | System and method for 3-D ultrasound imaging and motion estimation |
US6249591B1 (en) * | 1997-08-25 | 2001-06-19 | Hewlett-Packard Company | Method and apparatus for control of robotic grip or for activating contrast-based navigation |
US6352517B1 (en) * | 1998-06-02 | 2002-03-05 | Stephen Thomas Flock | Optical monitor of anatomical movement and uses thereof |
US6317506B1 (en) * | 1999-04-15 | 2001-11-13 | The United States Of America As Represented By The Secretary Of The Air Force | Measuring the characteristics of oscillating motion |
US6993167B1 (en) * | 1999-11-12 | 2006-01-31 | Polartechnics Limited | System and method for examining, recording and analyzing dermatological conditions |
NO314323B1 (no) * | 2000-03-24 | 2003-03-03 | Optonor As | Framgangsmåte og interferometer for måling av mikroskopisk vibrasjon |
WO2001082786A2 (en) * | 2000-05-03 | 2001-11-08 | Flock Stephen T | Optical imaging of subsurface anatomical structures and biomolecules |
JP4241038B2 (ja) * | 2000-10-30 | 2009-03-18 | ザ ジェネラル ホスピタル コーポレーション | 組織分析のための光学的な方法及びシステム |
WO2002086539A2 (en) * | 2001-04-24 | 2002-10-31 | National Research Council Of Canada | Method and apparatus for probing objects in motion |
CA2473587C (en) * | 2001-05-01 | 2014-07-15 | The General Hospital Corporation | Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties |
CA2413483A1 (en) * | 2001-12-26 | 2003-06-26 | Kevin R. Forrester | Motion measuring device |
AU2003236291A1 (en) * | 2002-03-28 | 2003-10-27 | Matsuuradenkosha Company Limited | Evaluation method and device for gel state or sol-gel state change of object |
US7123363B2 (en) * | 2003-01-03 | 2006-10-17 | Rose-Hulman Institute Of Technology | Speckle pattern analysis method and system |
US6809991B1 (en) * | 2003-01-21 | 2004-10-26 | Raytheon Company | Method and apparatus for detecting hidden features disposed in an opaque environment |
EP1596716B1 (de) * | 2003-01-24 | 2014-04-30 | The General Hospital Corporation | System und verfahren zur gewebeidentifizierung mittels interferometrie mit niedriger kohärenz |
AU2004262406B2 (en) * | 2003-08-01 | 2008-07-03 | Ge Healthcare Bio-Sciences Ab | Optical resonance analysis unit |
US7388971B2 (en) * | 2003-10-23 | 2008-06-17 | Northrop Grumman Corporation | Robust and low cost optical system for sensing stress, emotion and deception in human subjects |
US7221356B2 (en) * | 2004-02-26 | 2007-05-22 | Microsoft Corporation | Data input device and method for detecting an off-surface condition by a laser speckle size characteristic |
WO2006069443A1 (en) * | 2004-12-27 | 2006-07-06 | Bc Cancer Agency | Surface roughness measurement methods and apparatus |
US7496241B1 (en) * | 2005-09-08 | 2009-02-24 | Goodrich Corporation | Precision optical systems with performance characterization and uses thereof |
-
2007
- 2007-04-19 FR FR0754570A patent/FR2915077B1/fr active Active
-
2008
- 2008-04-18 JP JP2010503527A patent/JP5612463B2/ja not_active Expired - Fee Related
- 2008-04-18 CA CA2683878A patent/CA2683878C/fr not_active Expired - Fee Related
- 2008-04-18 US US12/596,025 patent/US20100121200A1/en not_active Abandoned
- 2008-04-18 EP EP08736401A patent/EP2136707A1/de not_active Withdrawn
- 2008-04-18 WO PCT/EP2008/054764 patent/WO2008132079A1/fr active Application Filing
Non-Patent Citations (1)
Title |
---|
See references of WO2008132079A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2010524533A (ja) | 2010-07-22 |
CA2683878C (fr) | 2015-11-17 |
US20100121200A1 (en) | 2010-05-13 |
FR2915077A1 (fr) | 2008-10-24 |
JP5612463B2 (ja) | 2014-10-22 |
WO2008132079A1 (fr) | 2008-11-06 |
CA2683878A1 (fr) | 2008-11-06 |
FR2915077B1 (fr) | 2010-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Narayanamurthy et al. | Skin cancer detection using non-invasive techniques | |
Fullwood et al. | Effect of substrate choice and tissue type on tissue preparation for spectral histopathology by Raman microspectroscopy | |
WO2008132079A1 (fr) | Dispositif d'aide au diagnostic et pronostic de modifications physiopathologiques des tissus | |
Gurjar et al. | Imaging human epithelial properties with polarized light-scattering spectroscopy | |
JP2020078563A (ja) | カテーテルによって全方位表示を得るための装置、デバイスおよび方法 | |
Alali et al. | Quantitative correlation between light depolarization and transport albedo of various porcine tissues | |
EP2186469B1 (de) | Verfahren und Vorrichtung für die Lokalisierung von Fluorophoren oder Absorbern in einem umgebenden Medium | |
FR2887426A1 (fr) | Systeme d'analyse electrophysiologique | |
CA2882784C (en) | Three-dimensional optical coherence tomography apparatus and its application | |
WO2008033909A2 (en) | Apparatus, probe and method for providing depth assessment in an anatomical structure | |
WO2006078973A2 (en) | Method and apparatus for high resolution spatially modulated fluorscence imaging and tomography | |
EP3054337A1 (de) | Dreidimensionale optische kohärenztomografievorrichtung und deren anwendung | |
Wilson et al. | Optical methods for quantitative and label-free sensing in living human tissues: principles, techniques, and applications | |
US8823954B2 (en) | Low coherence enhanced backscattering tomography and techniques | |
Wang et al. | Monte Carlo simulation of near infrared autofluorescence measurements of in vivo skin | |
Gardner et al. | Noninvasive determination of depth in transmission Raman spectroscopy in turbid media based on sample differential transmittance | |
Bailey et al. | Detection of precancerous lesions in the oral cavity using oblique polarized reflectance spectroscopy: a clinical feasibility study | |
Wang et al. | Condensed Monte Carlo modeling of reflectance from biological tissue with a single illumination–detection fiber | |
Laudereau | Acousto-optic imaging: challenges of in vivo imaging | |
Matveeva et al. | Additive simulation of Raman light scattering from skin cancer using the Monte Carlo method | |
Deán-Ben et al. | Light fluence estimation by imaging photoswitchable probes with temporally unmixed multispectral optoacoustic tomography | |
Khlynov et al. | Noninvasive polarization-based technique for hematocrit monitoring | |
Agrba et al. | Mechanical compression for biotissue image enhancement in optical coherence tomography | |
Karamata | Multiple scattering in wide-field optical coherence tomography | |
Kuznetsova et al. | Multiple-beam interferometry of turbid media with quasi-monochromatic light |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20091022 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20160215 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160826 |